Company · Private
Estuary Biotherapeutics, Inc.
Key figures
- SEC number
- 2138862
Source: SEC EDGAR filings and company facts; checked 19 Oct 2026
About
Private Menlo Park biotechnology company developing AAV gene therapies for autosomal dominant polycystic kidney disease (ADPKD).
Rounds and raises
16 Oct 2026
Form D: $41M sold of $104M offered, Biotechnology SEC
Source: SEC EDGAR Form D and the linked articles. All raises this week
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.